PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

China flag China · Delayed Price · Currency is CNY
41.00
+1.20 (3.02%)
At close: Mar 6, 2026
Market Cap5.64B +36.5%
Revenue (ttm)667.47M +29.9%
Net Income36.59M +428.1%
EPS0.26 +411.0%
Shares Out137.54M
PE Ratio160.29
Forward PEn/a
Dividend0.50 (1.22%)
Ex-Dividend DateJan 13, 2026
Volume5,705,579
Average Volume7,153,367
Open39.48
Previous Close39.80
Day's Range39.48 - 41.41
52-Week Range22.21 - 67.97
Beta1.45
RSI43.33
Earnings DateApr 29, 2026

About SHE:301230

PharmaResources (Shanghai) Co., Ltd. engages in new drug research, development, and commercial production in China. It offers small molecule drug CRO, CDMO, and CMO. The company also involved in drug discovery, research, and development of pharmaceutical processes; and customized and commercial production of APIs, and key intermediates. It serves global pharmaceutical and biotechnology companies. PharmaResources (Shanghai) Co., Ltd. was founded in 2007 and is based in Shanghai, China [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 1,085
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301230
Full Company Profile

Financial Performance

In 2024, SHE:301230's revenue was 544.47 million, an increase of 11.18% compared to the previous year's 489.72 million. Earnings were 17.08 million, a decrease of -54.59%.

Financial Statements